Cystatin F has recently been found to play a role in modulating disease severity in pre-clinical mouse models of demyelination, including experimental autoimmune encephalomyelitis (EAE), as well as toxin and genetic models of disease [31–34]. Here, CST7 is linked to Peripheral demyelination.